NDC 71610-225 – Lorazepam

Lorazepam .5 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CIV

Product NDC71610-225

Product details

Brand name
Lorazepam
Generic name
Lorazepam
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA078203
Marketed since
May 16, 2023
Listing expires
December 31, 2026
Pharmacologic class
Benzodiazepine

Active ingredients

Uses, dosage, side effects and warnings for Lorazepam →

Package NDC codes (11)

Package NDCDescriptionSince
71610-225-1010 TABLET in 1 BOTTLE (71610-225-10)Nov 2, 2023
71610-225-1515 TABLET in 1 BOTTLE (71610-225-15)May 16, 2023
71610-225-2020 TABLET in 1 BOTTLE (71610-225-20)Nov 2, 2023
71610-225-2828 TABLET in 1 BOTTLE (71610-225-28)Apr 12, 2024
71610-225-3030 TABLET in 1 BOTTLE (71610-225-30)May 16, 2023
71610-225-4545 TABLET in 1 BOTTLE (71610-225-45)May 16, 2023
71610-225-5360 TABLET in 1 BOTTLE (71610-225-53)May 16, 2023
71610-225-6090 TABLET in 1 BOTTLE (71610-225-60)May 16, 2023
71610-225-70120 TABLET in 1 BOTTLE (71610-225-70)Jun 19, 2023
71610-225-75150 TABLET in 1 BOTTLE (71610-225-75)Jun 19, 2023
71610-225-80180 TABLET in 1 BOTTLE (71610-225-80)May 16, 2023

Other Lorazepam products